Last reviewed · How we verify
Probiotic mix preparation
Probiotic mix preparation is a Small molecule drug developed by Centro Pediatrico Albina de Patino. It is currently in Phase 1 development. Also known as: Probiotic.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Probiotic mix preparation |
|---|---|
| Also known as | Probiotic |
| Sponsor | Centro Pediatrico Albina de Patino |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System (NA)
- Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes (PHASE2, PHASE3)
- Probiotics for Preterm Infants
- Probiotic and Prebiotic Supplementation in Elite Athletes with Spinal Cord Injury (NA)
- Study of the Safety and Tolerability of the Broad-spectrum Probiotic Medicine "AS-Probionorm" (PHASE1)
- A Randomized, Controlled Trial of Probiotic and Peanut Oral Immunotherapy (PPOIT) in Inducing Tolerance in Hong Kong Children With Peanut Allergy Compared With Oral Immunotherapy (OIT) Alone and With Placebo (NA)
- The Efficacy of Probiotics for the Treatment of Alcohol Use Disorder Among Adult Males (NA)
- Effects of "For-Baby" Supplementation on Young Children's Physical Growth and Diarrhea Episodes (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Probiotic mix preparation CI brief — competitive landscape report
- Probiotic mix preparation updates RSS · CI watch RSS
- Centro Pediatrico Albina de Patino portfolio CI
Frequently asked questions about Probiotic mix preparation
What is Probiotic mix preparation?
Who makes Probiotic mix preparation?
Is Probiotic mix preparation also known as anything else?
What development phase is Probiotic mix preparation in?
Related
- Manufacturer: Centro Pediatrico Albina de Patino — full pipeline
- Also known as: Probiotic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing